Estradiol metabolites are potent mitogenic substances for human ovarian cancer cells

European Journal of Gynaecological Oncology

Volumn 26, Issue 4, 2005, Pages 383-385

  Seeger, H ^a   Wallwiener, D ^a   Kraemer, E ^a   Mueck, A O ^a  

^a University Women's Hospital   (Germany)

Author keywords

Estradiol metabolites; Ovarian cancer cells; Proliferation

Indexed keywords

16 ALPHA HYDROXYESTERONE; 2 HYDROXYESTRADIOL; 4 HYDROXYESTRADIOL; DRUG METABOLITE; ESTRADIOL; ESTRADIOL DERIVATIVE; MITOGENIC AGENT; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER RISK; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; HORMONAL THERAPY; HUMAN; HUMAN CELL; MITOGENESIS; OVARY CANCER; POSTMENOPAUSE;

APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; ESTRADIOL; FEMALE; HUMANS; MITOGENS; OVARIAN NEOPLASMS;

EID: 23744501325     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Greenlee R.T., Murray T., Bolden S., Wingo P.A.: "Cancer statistics, 2000". Cancer J. Clin., 2000, 50, 7.
2. Auersperg N., Wong A.S., Choi K.C., Kang S.K., Leung P.C.: "Ovarian surface epithelium: biology, endocrinology, and pathology". Endocr. Rev., 2001, 22, 255.
3. Langdon S.P., Hirst G.L., Miller E.P., Hawkins R.A., Tesdale A.L., Smyth J.F. et al.: "The regulation of growth and protein expression by estrogen in vitro: a study of 8 human ovarian carcinoma cell lines". J. Steroid. Biochem. Mol. Biol., 1994, 50, 131.
4. Galtier-Dereure F, Capony F., Maudelonde T., Rochefort H.: "Estradiol stimulates cell growth and secretion of procathepsin D and a 120-kilodalton protein in the human ovarian cancer cell line BG-1". J. Clin. Endocrinol. Metab., 1992, 75, 1497.
5. Mueck A.O., Seeger H., Lippert T.H.: "Estradiol metabolism and malignant disease - Review". Maturitas, 2002, 43, 1.
6. Lippert T.H., Seeger H., Mueck A.O.: "The impact of endogenous estradiol metabolites on carcinogenesis". Steroids., 2000, 65, 357.
7. Andreotti P.E., Thornthwaite J.T., Morse LS.: "ATP Tumor Chemosensitivity Assay". In: "Bioluminescence and Chemiluminescence: Current Status". Stanley, R., Kricka, L.J. (eds.), Chichester, J. Wiley & Sons, 1991, 417.
8. Rodriguez C., Patel A.V., Calle E.E., Jacob E.J., Thun M.J.: "Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women". JAMA, 2001, 285, 1460.
9. Lacey J.V. Jr., Mink P.J., Lubin J.H., Sherman M.E., Troisi R., Hartge P. et al.: "Menopausal hormone replacement therapy and risk of ovarian cancer". JAMA, 2002, 288, 334.
10. Anderson G.L., Judd H.L., Kaunitz A.M., Barad D.H., Beresford S.A., Pettinger M. et al.: "Effects of estrogen plus progestin on gynaecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial". JAMA, 2003, 290, 1739.
11. Coughlin S.S., Giustozzi A., Smith S.J., Lee N.C.: "A meta-analysis of estrogen replacement therapy and risk of epithelial ovarian cancer". J. Clin. Epidemiol 2000, 53, 367.
12. Negri E., Tzonou A., Beral V., Lagiou P., Trichopoulos D., Parazzini F. et al.: "Hormonal therapy for menopause and ovarian cancer in a collaborative re-analysis of European studies". Int. J. Cancer, 1999, 80, 848.
13. Nash J.D., Ozols R.F., Smyth J.F., Hamilton T.C.: "Estrogen and antiestrogen effects on the growth of human epithelial ovarian cancer in vitro". Obstet. Gynecol., 1989, 73, 1009.
14. Fishman J., Martucci C.: "Dissociation of biological activities in metabolites of estradiol". In: "Estrogens in the environment". McLachlan JA (ed.), North-Holland, Elsevier, 1980, 131.
15. Fishman J., Martucci C.: "Biological properties of 16a-hydroxyestrone: Implications in estrogen physiology and pathophysiology". J. Clin. Endocrinol. Metabol., 1980, 51, 611.
16. Lippert T.H., Seeger H., Mueck A.O.: "Metabolism of endogenous estrogens". In: "Estrogens and Antiestrogens - Handbook of Experimental Pharmacology". Oettel M., Schillinger E. (eds.), New York, Springer, 1999, 243.
17. Yager J.D., Liehr J.G.: "Molecular mechanisms of estrogen carcinogenesis". Annu. Rev. Pharmacol. Toxicol., 1996, 36, 203.
18. Mueck A.O., Seeger H., Wallwiener D., Huober J.: "Is the combination with 2-Methoxy-Estradiol able to reduce the dosages of chemotherapeutics in treatment of human ovary cancer"? Eur. J. Gynaecol. Oncol., 2004, 25, 699.